ImmunologyBlood AdvancesPeer-reviewed
Antithrombotic Efficacy and Bleeding Risks of Vaccine-Induced Immune Thrombotic Thrombocytopenia Treatments
Halina Hoi Laam Leung, Zohra Ahmadi, Brendan Lee…·Beng H. Chong
This study evaluates anticoagulants and IVIg for treating VITT, finding danaparoid reduces IgG-PF4 binding and FcγRIIa blockade is most effective for thrombosis and thrombocytopenia.
8 citations